Respiratory Syncytial Virus Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: RSV-Positive Children <5 Years Presenting to Pediatric Emergency Departments in Türkiye: TRUST-RSV
The TRUST-RSV trial in Türkiye is studying RSV-positive children under 5 presenting to pediatric emergency departments, and the study is cur…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Study Evaluating the Impact of Using Triplex Rapid Diagnostic Tests (SARS-CoV-2/Influenza/RSV) on Antibiotic Prescribing [NA]
A clinical trial evaluating whether using a triplex rapid diagnostic test for SARS-CoV-2, influenza, and RSV changes antibiotic prescribing …
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: RSV Burden in Hong Kong
A clinical trial led by The Chinese University of Hong Kong is studying the burden of respiratory syncytial virus (RSV) in Hong Kong and is …
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: COVID-19 Impact on RSV Emergency Presentations
A recruiting clinical trial studying the impact of COVID-19 on emergency presentations for bronchiolitis associated with Respiratory Syncyti…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients [Phase 4]
Phase 4 trial update assessing immune response to an RSV vaccine in recipients of stem cell transplantation and CAR-T therapy, currently not…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Study of an RSV-hMPV-PIV3 Trivalent Vaccine Candidate VXB-251 in Older Adults [Phase 1]
Phase 1 clinical trial update for VXB-251, a trivalent vaccine targeting RSV, human metapneumovirus, and parainfluenza virus type 3, studied…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants
Pfizer's ABRYSVO maternal RSV vaccine is listed as active but not recruiting in a trial evaluating infant effectiveness.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: A Study to Learn About ABRYSVO Vaccine in Older Adults to Prevent Severe Respiratory Syncytial Virus (RSV) Disease
Pfizer is conducting a study to evaluate ABRYSVO for preventing severe respiratory syncytial virus infection in older adults, with the trial…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons [Phase 2]
A Phase 2 clinical trial is evaluating the immunogenicity of the RSVPreF3 vaccine in immunocompromised adults, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Effectiveness of Immunization in Preventing Severe Acute Respiratory Infection RSV
A clinical trial is evaluating the effectiveness of an immunization to prevent severe acute respiratory infections caused by Respiratory Syn…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older [Phase 1, Phase 2]
Phase 1/2 study of Sanofi Pasteur's lipid nanoparticle-encapsulated mRNA vaccine candidate for human metapneumovirus and respiratory syncyti…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies
Clinical trial update on a next-generation non-invasive passive detection technology for COVID-19/SARS-CoV-2, with the study currently activ…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell) [Phase 3]
Phase III trial evaluating a recombinant Respiratory Syncytial Virus vaccine produced in CHO cells is currently recruiting. No results are r…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Promotion of RSV Immunization Through Multiple Efforts [Phase 3]
Phase 3 trial update from Washington University School of Medicine focusing on promoting RSV vaccination during pregnancy; the study status …
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Diagnosis and Treatment Status and Medical Burden of Respiratory Syncytial Virus Infection in Children in China
A ClinicalTrials.gov entry from Beijing Children's Hospital provides an update on the NCT07264478 study. It describes the study's active-not…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: A Post-marketing Surveillance Study of Beyfortus (Nirsevimab) in Republic of Korea
A post-marketing surveillance study in South Korea to monitor safety and real-world outcomes of Beyfortus (nirsevimab) for respiratory syncy…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: RSV Vaccine in Transplant Recipients [Phase 3]
Phase 3 trial evaluating an RSV vaccine in immunosuppressed transplant recipients is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools
The CARE-ID trial is currently recruiting to study dynamics of respiratory infections in children and transmission in households and schools…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults [Phase 4]
A Phase 4 clinical trial is evaluating the effectiveness of a bivalent RSV prefusion F protein-based vaccine to prevent RSV-related hospital…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months [Phase 1]
Clinical trial update describing safety, tolerability, and immunogenicity assessment of Moderna’s mRNA vaccines mRNA-1345 and mRNA-1365 in i…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Genotype and Disease Burden of RSV in Older Vietnamese Adults (RSV: Respiratory Syncytial Virus )
A clinical trial studying the genotype and disease burden of respiratory syncytial virus (RSV) in older adults in Vietnam. The study is curr…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)
An ongoing Pfizer-sponsored real-world study in Australia is evaluating how effective the maternal RSVpreF vaccine is at preventing respirat…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination [Phase 3]
A Phase 3 trial evaluating administering Nirsevimab to infants, with or without maternal RSV vaccination, to prevent RSV infection. The stud…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Preparedness Through Respiratory Virus Epidemiology and Community Engagement
A University of California, San Diego-led clinical trial studies respiratory virus epidemiology and community engagement to improve prepared…
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings [NA]
The document reports on the clinical validation of Aptitude Medical Systems' Metrix Respiratory Panel for detecting COVID-19, Influenza A, I…